ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
6.47
-0.31 (-4.57%)
Dec 5, 2025, 4:00 PM EST - Market closed
ImageneBio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Revenue | 0.8 | 3.5 | 7.96 |
| Revenue Growth (YoY) | -89.95% | -56.04% | - |
| Gross Profit | 0.8 | 3.5 | 7.96 |
| Selling, General & Admin | 17.88 | 8.39 | 7.96 |
| Research & Development | 29.01 | 32.11 | 21.93 |
| Operating Expenses | 46.89 | 40.5 | 29.89 |
| Operating Income | -46.09 | -37 | -21.93 |
| Interest & Investment Income | 0.03 | 0.37 | 1.19 |
| Other Non Operating Income (Expenses) | 3.15 | 0.07 | -0.14 |
| Pretax Income | -43.31 | -36.56 | -20.87 |
| Income Tax Expense | -0.06 | 0.01 | 0.28 |
| Net Income | -43.25 | -36.57 | -21.15 |
| Preferred Dividends & Other Adjustments | 10.11 | 11.82 | 10.89 |
| Net Income to Common | -53.36 | -48.38 | -32.04 |
| Shares Outstanding (Basic) | 393 | 391 | 321 |
| Shares Outstanding (Diluted) | 393 | 391 | 321 |
| Shares Change (YoY) | 22.60% | 21.97% | - |
| EPS (Basic) | -0.14 | -0.12 | -0.10 |
| EPS (Diluted) | -0.14 | -0.12 | -0.10 |
| Free Cash Flow | -44.1 | -21.32 | -18.54 |
| Free Cash Flow Per Share | -0.11 | -0.05 | -0.06 |
| Gross Margin | 100.00% | 100.00% | 100.00% |
| Operating Margin | -5761.13% | -1057.14% | -275.37% |
| Profit Margin | -6669.75% | -1382.40% | -402.39% |
| Free Cash Flow Margin | -5512.63% | -609.11% | -232.83% |
| EBITDA | -46.07 | -35.86 | -19.52 |
| EBITDA Margin | - | - | -245.15% |
| D&A For EBITDA | 0.02 | 1.14 | 2.41 |
| EBIT | -46.09 | -37 | -21.93 |
| EBIT Margin | - | - | -275.37% |
Source: S&P Capital IQ. Standard template.
Financial Sources.